Cargando…

ATP2C2 Has Potential to Define Tumor Microenvironment in Breast Cancer

Tumor microenvironment (TME) is vital for the occurrence and development of breast cancer (BRCA). However, it remains challenging to understand the dynamic modulation of the stromal and immune components comprehensively in TME. Herein, we used ESTIMATE and CIBERSORT algorithm to estimate the number...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Jiazhou, Wei, Yuxian, Wu, Yushen, Li, Jie, Sun, Jiazheng, Ren, Guosheng, Li, Hongzhong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8079766/ https://www.ncbi.nlm.nih.gov/pubmed/33936088 http://dx.doi.org/10.3389/fimmu.2021.657950

Ejemplares similares

The Novel Methylation Biomarker NPY5R Sensitizes Breast Cancer Cells to Chemotherapy
por: Liu, Jiazhou, et al.
Publicado: (2022)

Breast-Conserving Therapy Has Better Prognosis for Tumors in the Central and Nipple Portion of Breast Cancer Compared with Mastectomy: A SEER Data-Based Study
por: Wang, Jing, et al.
Publicado: (2021)

FGFR blockade boosts T cell infiltration into triple-negative breast cancer by regulating cancer-associated fibroblasts
por: Wu, Yushen, et al.
Publicado: (2022)

Expression patterns of E2F transcription factors and their potential prognostic roles in breast cancer
por: Li, Yunhai, et al.
Publicado: (2018)

Pharmaceutical targeting Th2-mediated immunity enhances immunotherapy response in breast cancer
por: Chen, Yuru, et al.
Publicado: (2022)

Editorial: Cancer cell-intrinsic and -extrinsic factors affecting tumor immune evasion
por: Sun, Jiazheng, et al.
Publicado: (2023)

NLRP1 Overexpression Is Correlated with the Tumorigenesis and Proliferation of Human Breast Tumor
por: Wei, Yuxian, et al.
Publicado: (2017)

ATP2C2 as a novel immune-related marker that defines the tumor microenvironment in triple-negative breast cancer
por: Zhao, Mingyuan, et al.
Publicado: (2023)

Circular RNA 0001073 Attenuates Malignant Biological Behaviours in Breast Cancer Cell and Is Delivered by Nanoparticles to Inhibit Mice Tumour Growth
por: Yi, Ziying, et al.
Publicado: (2020)

Efficacy and safety of neoadjuvant chemotherapy regimens for triple-negative breast cancer: a network meta-analysis
por: Li, Yunhai, et al.
Publicado: (2019)

Crosstalk of necroptosis and pyroptosis defines tumor microenvironment characterization and predicts prognosis in clear cell renal carcinoma
por: Fu, Liangmin, et al.
Publicado: (2022)

Cross-talk between cuproptosis and ferroptosis regulators defines the tumor microenvironment for the prediction of prognosis and therapies in lung adenocarcinoma
por: Shen, Yefeng, et al.
Publicado: (2023)

Chamaejasmenin B, an Inhibitor for Metastatic Outgrowth, Reversed M2-Dominant Macrophage Polarization in Breast Tumor Microenvironment
por: Li, Qi, et al.
Publicado: (2021)

Histone Acetylation Regulator-Mediated Acetylation Patterns Define Tumor Malignant Pathways and Tumor Microenvironment in Hepatocellular Carcinoma
por: Xu, Yuyan, et al.
Publicado: (2022)

Cyclooxygenase-2 in tumor-associated macrophages promotes metastatic potential of breast cancer cells through Akt pathway
por: Gan, Lu, et al.
Publicado: (2016)

Integration of Tumor Microenvironment in Patient-Derived Organoid Models Help Define Precision Medicine of Renal Cell Carcinoma
por: Wang, Bingran, et al.
Publicado: (2022)

Forward and Reverse Signaling Mediated by Transmembrane Tumor Necrosis Factor-Alpha and TNF Receptor 2: Potential Roles in an Immunosuppressive Tumor Microenvironment
por: Qu, Yang, et al.
Publicado: (2017)

CD2 Is a Novel Immune-Related Prognostic Biomarker of Invasive Breast Carcinoma That Modulates the Tumor Microenvironment
por: Chen, Yanzhu, et al.
Publicado: (2021)

Exhausted CD8+T Cells in the Tumor Immune Microenvironment: New Pathways to Therapy
por: Jiang, Weiqin, et al.
Publicado: (2021)

Crosstalk of three novel types of programmed cell death defines distinct microenvironment characterization and pharmacogenomic landscape in breast cancer
por: Xu, Lijun
Publicado: (2022)

Different Expression Characteristics of LAG3 and PD-1 in Sepsis and Their Synergistic Effect on T Cell Exhaustion: A New Strategy for Immune Checkpoint Blockade
por: Niu, Bailin, et al.
Publicado: (2019)

Functions of Group 2 Innate Lymphoid Cells in Tumor Microenvironment
por: Xiong, Jia, et al.
Publicado: (2019)

A Ribosome-Related Prognostic Signature of Breast Cancer Subtypes Based on Changes in Breast Cancer Patients’ Immunological Activity
por: Luan, Tiankuo, et al.
Publicado: (2023)

Comprehensive Analysis of Pyroptosis-Related Genes and Tumor Microenvironment Infiltration Characterization in Breast Cancer
por: Wu, JianBin, et al.
Publicado: (2021)

EZH2 Inhibitors Suppress Colorectal Cancer by Regulating Macrophage Polarization in the Tumor Microenvironment
por: Li, Chen, et al.
Publicado: (2022)

Hyperthermia Targeting the Tumor Microenvironment Facilitates Immune Checkpoint Inhibitors
por: Li, Zihui, et al.
Publicado: (2020)

Identification of disulfidptosis-related subtypes, characterization of tumor microenvironment infiltration, and development of a prognosis model in breast cancer
por: Liang, Jiahui, et al.
Publicado: (2023)

Inducing ferroptosis has the potential to overcome therapy resistance in breast cancer
por: Qi, Xiaowen, et al.
Publicado: (2022)

Radiomics Assessment of the Tumor Immune Microenvironment to Predict Outcomes in Breast Cancer
por: Han, Xiaorui, et al.
Publicado: (2022)

Editorial: Tumor microenvironment, immunotherapy, and drug resistance in breast and gastrointestinal cancer
por: Deng, Xinpei, et al.
Publicado: (2023)

Characteristics of the immunogenicity and tumor immune microenvironment in HER2-amplified lung adenocarcinoma
por: Wang, Qinyang, et al.
Publicado: (2022)

Immunotherapy: Reshape the Tumor Immune Microenvironment
por: LV, Bingzhe, et al.
Publicado: (2022)

Metabolic Interdependency of Th2 Cell-Mediated Type 2 Immunity and the Tumor Microenvironment
por: Schreiber, Simon, et al.
Publicado: (2021)

Immunoregulation and clinical significance of neutrophils/NETs-ANGPT2 in tumor microenvironment of gastric cancer
por: Yang, Shifeng, et al.
Publicado: (2022)

Target tumor microenvironment by innate T cells
por: Li, Yan-Ruide, et al.
Publicado: (2022)

Meta-analysis of associations between DLG5 R30Q and P1371Q polymorphisms and susceptibility to inflammatory bowel disease
por: Li, Yunhai, et al.
Publicado: (2016)

Editorial: Stromal and immune microenvironment in breast cancer metastasis
por: Lu, Xin, et al.
Publicado: (2022)

Editorial: The role of angiogenesis and immune response in tumor microenvironment of solid tumor
por: Guo, Zichao, et al.
Publicado: (2023)

The role of glutamate receptors in the regulation of the tumor microenvironment
por: Koda, Stephane, et al.
Publicado: (2023)

Pan-cancer analysis identifies PD-L2 as a tumor promotor in the tumor microenvironment
por: Lv, Jingfang, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ro18sro3n9k5utkqn94m2np8vk